You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

AML il-6 tocilizumab

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Malignant Pleural Effusion, Malignant Ascites Trial in Pittsburgh (Tocilizumab)

Not yet recruiting
  • Malignant Pleural Effusion
  • Malignant Ascites
  • Pittsburgh, Pennsylvania
    Allegheny Health Network Cancer Institute
Aug 30, 2023

Glycogen Depletion Trial in Copenhagen (Tocilizumab/Actemra® (Roche), Saline 9%)

Recruiting
  • Glycogen Depletion
  • Tocilizumab/Actemra® (Roche)
  • Saline 9%
  • Copenhagen, Capital Region, Denmark
    Centre for Physical Activity Research, Rigshospitalet Section 76
Apr 21, 2022

Interleukin-6 Inhibition, Physical Stress, Appetitive Behavior Trial in Copenhagen Ø (Tocilizumab Injectable Product, Saline

Completed
  • Interleukin-6 Inhibition
  • +2 more
  • Tocilizumab Injectable Product
  • Saline 0.9% 100 ml NaCl 0.9% will be infused over 1 hour
  • Copenhagen Ø, Denmark
    Center For Physical Activity (CFAS)
Aug 19, 2022

Acute Myeloid Leukemia (AML) Trial in Nantes (Tocilizumab)

Active, not recruiting
  • Acute Myeloid Leukemia (AML)
  • Nantes, France
    CHU of Nantes
Dec 16, 2022

Kidney Transplantation, Graft Failure Trial in Toulouse (Tocilizumab)

Recruiting
  • Kidney Transplantation
  • Graft Failure
  • Toulouse, France
    CHU Toulouse
Mar 15, 2022

Inpatient COVID-19 Treatments

Active, not recruiting
  • COVID-19
  • Initiation of IL6Ri (tocilizumab or sarilumab) versus JAKi (baricitinib or tofacitinib) added to systemic corticosteroids of interest (CSI)
  • New York, New York
    Aetion, Inc.
Jan 12, 2023

COVID-19 Trial in New York (Tocilizumab)

Active, not recruiting
  • COVID-19
  • New York, New York
    Memorial Sloan Kettering Cancer Center
Jan 21, 2022

Unresectable Pancreatic Carcinoma Trial in Herlev, Oslo (Tocilizumab, Gemcitabine, nab-Paclitaxel)

Active, not recruiting
  • Unresectable Pancreatic Carcinoma
  • Herlev, Denmark
  • +1 more
Mar 15, 2022

Graves Ophthalmopathy Trial in Italy (Tocilizumab 20 Mg/mL Intravenous Solution, MethylPREDNISolone Injectable Solution)

Recruiting
  • Graves Ophthalmopathy
  • Tocilizumab 20 Mg/mL Intravenous Solution
  • MethylPREDNISolone Injectable Solution
  • Milano, MI, Italy
  • +3 more
Aug 3, 2022

Adamantinomatous Craniopharyngioma, Recurrent Adamantinomatous Craniopharyngioma Trial in Worldwide (Tocilizumab)

Recruiting
  • Adamantinomatous Craniopharyngioma
  • Recurrent Adamantinomatous Craniopharyngioma
  • Aurora, Colorado
  • +17 more
Jan 8, 2023

Rheumatoid Arthritis Trial in China (IL-6R Monoclonal Antibody Injection 4mg/kg, IL-6R Monoclonal Antibody Injection 6mg/kg,

Completed
  • Rheumatoid Arthritis
  • IL-6R Monoclonal Antibody Injection 4mg/kg
  • +3 more
  • Baoding, China
  • +4 more
Feb 24, 2022

Rheumatoid Arthritis, JAK Inhibitor, IL-6 Inhibitor Trial in Nagasaki (filgotinib 200mg/day, subcutaneous tocilizumab

Recruiting
  • Rheumatoid Arthritis
  • +4 more
  • filgotinib 200mg/day
  • subcutaneous tocilizumab 162mg/biweekly
  • Nagasaki, Japan
    Nagasaki University Hospital
Oct 23, 2021

Pyrexia Trial in Zürich (Actemra)

Recruiting
  • Pyrexia
  • Zürich, Switzerland
    University Hospital Zurich, Clinic of Dermatology
Sep 29, 2021

Takayasu Arteritis, Tocilizumab, Adalimumab Trial in Shanghai (Tocilizumab, Adalimumab)

Recruiting
  • Takayasu Arteritis
  • +3 more
  • Tocilizumab
  • Adalimumab
  • Shanghai, Shanghai, China
    Department of Rheumatology in Zhongshan hospital, Fudan Universi
Aug 7, 2021

Tocilizumab in Patients With Severe COVID-19

Recruiting
  • Severe COVID 19 Pneumonia
  • Tocilizumab
  • Ciudad autónoma de Buenos Aires, Caba, Argentina
    Hospital Italiano de Buenos AIres
Jun 10, 2021

Rheumatoid Arthritis Trial (TNFi, Anti-IL6, JAKi)

Not yet recruiting
  • Rheumatoid Arthritis
  • (no location specified)
Mar 22, 2022

Serum IL-6 and Soluble IL-6 Receptor in Severe COVID-19

Unknown status
  • COVID-19
  • Severe Pneumonia
  • Tocilizumab 20 MG/ML Intravenous Solution [ACTEMRA]
  • Zagreb, Croatia
    University Hospital for Infectious Diseases "Dr Fran Mihaljevic"
Nov 10, 2020

HIV Trial in Cleveland (tocilizumab, Placebo)

Completed
Has Results
  • HIV Infections
  • Cleveland, Ohio
    Case Clinical Research Site
Dec 15, 2020

Diffuse Astrocytoma, IDH-Wildtype, Recurrent Glioblastoma Trial in United States (biological, procedure, radiation)

Suspended
  • Diffuse Astrocytoma, IDH-Wildtype
  • Recurrent Glioblastoma
  • Atezolizumab
  • +5 more
  • Los Angeles, California
  • +73 more
Jan 31, 2023

Anti-IL6 and Corticosteroid Monotherapy vs Combination in

Recruiting
  • Critical Illness
  • +2 more
  • Interleukin 6 (IL6) Antagonist
  • +2 more
  • Riyadh, Saudi Arabia
    King Faisal Specialist Hospital and Research Center
Mar 4, 2021

Obesity, Healthy Trial in Copenhagen (Tocilizumab infusion, Saline 0.9%)

Completed
  • Obesity
  • Healthy
  • Tocilizumab infusion
  • Saline 0.9%
  • Copenhagen, Denmark
    Rigshospitalet, Centre of Inflammation and Metabolism (CIM) Cent
Oct 6, 2020

Coronary Disease, Myocardial Infarction Trial in Oslo, Trondheim (Tocilizumab, Sodium chloride 0.9%)

Completed
  • Coronary Disease
  • Myocardial Infarction
  • Oslo, Norway
  • +2 more
Feb 28, 2021

Corona Virus Disease 2019 (COVID-19) Trial in Lahore (Tocilizumab)

Completed
  • Corona Virus Disease 2019 (COVID-19)
  • Lahore, Punjab, Pakistan
    The University of Lahore
Dec 30, 2020

Interleukin 6 Receptor Antagonists in Corona Virus Disease 19

Recruiting
  • Corona Virus Infection
  • ELISA
  • Assiut, Egypt
    AssiutU
Feb 2, 2023

Corona Virus Disease Trial in Copenhagen, Hillerød (RoActemra iv, RoActemra sc, Kevzara sc)

Terminated
  • Corona Virus Disease
  • RoActemra iv
  • +3 more
  • Copenhagen, Denmark
  • +1 more
Oct 8, 2020